Nutritional one-two punch may slow retinitis pigmentosa

Article

A recent analysis of three clinical trials has provided further evidence that a supplement of pure vitamin A combined with an omega-3 rich fatty acid diet can slow vision loss in adults with the common forms of retinitis pigmentosa.

"It does not prevent, cure, or reverse the disease," cautioned Jeff Anshel, OD, FAAO, president of the Ocular Nutrition Society. "It just slows the progression." But with a disease that has no other effective treatments, the positive study data can be seen as a glass half full. "Anything that keeps people with their vision longer is a good thing," he said.

Eliot Berson, MD, and colleagues of Harvard Medical School and the Massachusetts Eye and Ear Infirmary reported that RP patients who take a high dose of vitamin A pal-mitate and consume a diet rich in omega-3 lost an average of 0.59 letters of visual acuity per year. Those taking similar amounts of vitamin A palmitate but consuming lower amounts of omega-3s lost an average of 1.0 letter per year, as measured by Early Treatment or Diabetic Retinopathy Study (EDTRS) distance acuity. The paper was published in the February issue of Archives of Ophthalmology. [Arch Ophthalmol. Published online 13 Feb 2012)

He also noted that the analysis found only vitamin A palmitate, not other forms vitamin A, was effective in postponing vision loss in RP. "Beta-carotene or carrots are not a suitable substitute for vitamin A palmitate in the context of this treatment," Dr. Berson said.

Analyzing data from a total of 357 patients from three clinical trials, each lasting between 4 and 6 years, Dr. Berson and colleagues found that daily doses of 15,000 IU of oral vitamin A palmitate in combination with eating at least 0.2 gram of omega-3 fatty acids daily-the equivalent of one to two 3-ounce servings of oily fish per week-slowed the rate of decline in retinal function.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Connecting with colleagues, taking courses, and gathering insight for Optometry Times
Ashley Mills, CEO of The Vision Council, gives insight into the decision to move to a single annual meeting and shares the vision for the meeting going forward.
© 2025 MJH Life Sciences

All rights reserved.